首页> 外文期刊>Journal of King Saud University >Isolation and characterisation of Streptomyces sp. Strain GLD25 with antimicrobial and antioxidant effects from Gueldaman cave (GLD1), Akbou-Algeria
【24h】

Isolation and characterisation of Streptomyces sp. Strain GLD25 with antimicrobial and antioxidant effects from Gueldaman cave (GLD1), Akbou-Algeria

机译:链霉菌 sp的分离与表征。 菌株GLD25具有抗菌和抗氧化效果的Gueldaman Cave(GLD1),Akbou-Algeria

获取原文
           

摘要

ObjectivesThe present study aimed to isolate potential antimicrobial and antioxidantStreptomyces spfrom cave areas ofAlgeria.MethodsStreptomycessp.GLD25 was identified by biochemical, physiological and molecular analysis. The antimicrobial activity has been carried out by well diffusion method, microplates method has been used to perform the MIC values of the organic extracts. The antioxidant capacity of the extract was tested by DPPH and FRAP methods. GC–MS analysis was used to study the chemical profile of the crude active extract.ResultsThe novel strainStreptomycessp. GLD25 was isolated from Gueldaman cave in Algeria showed potential antioxidant and antimicrobial properties. According to the results of morphological, biochemical characteristics and complete 16S rRNA sequence, the strain revealed 99.71% of similarity withStreptomyces cyaneofuscatusstrain WKFF71.The significant inhibition zone of the crude extract and MIC value were 30?mm and 0,015?mg/mL respectively againstStaphylococcus aureusandBacillus subtilis. In addition, the extract showed good antioxidant activity with IC50?=?20,12?mg/mL?±?2,05 for DPPH and IC50?=?8,80?mg/mL?±?0,2 for ferric reducing activity. The fundamental metabolites of the active extract were identified using GC–MS were Diisooctyl-phthalate, 6-hydroxy-heptanoic acid, Hexadecanoic acid, Benzeneacetic acid and 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid.ConclusionOverall, theStreptomycessp.GLD25 isolated from Gueldamen cave have the potential to produce antimicrobials and antioxidants compounds with important biotechnological and medical applications.
机译:目前目前的研究旨在分离潜在的抗微生物和抗氧化物抑制酵母菌Sp从Hgeria.methodsstreptomycessp.gld25通过生化,生理和分子分析鉴定。通过孔扩散法进行了抗微生物活性,已经使用微孔板方法进行有机萃取物的MIC值。通过DPPH和FRAP方法测试提取物的抗氧化能力。 GC-MS分析用于研究粗药物的化学曲线。提取物新的菌株菌株。在阿尔及利亚的Gueldaman洞穴中被隔离GLD25显示出潜在的抗氧化剂和抗微生物性质。根据形态学,生化特征和完整的16S rRNA序列的结果,菌株揭示了豆类菌uscatusstrain wkff71的99.71%的相似性。粗提取物和麦克风值的显着抑制区分别为30?mm和0.015?mg / ml抵抗含量抵抗枯草芽孢杆菌。此外,提取物显示良好的抗氧化活性与IC50?= 20,12?mg / mlα±2,05用于DPPH和IC50?=?8,80?mg / ml?±0,2用于铁氧化物活动。使用GC-MS鉴定活性提取物的基本代谢物是二亮庚基 - 邻苯二甲酸酯,6-羟基 - 庚酸,十六烷酸,苯甲酸和3-(3,5-二叔丁基-4-羟基苯基)丙酸酸.Conclusionoverall,从古尔曼森洞穴中分离的TheStromycessp.gld25有可能产生具有重要生物技术和医疗应用的抗微生物和抗氧化剂化合物。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号